Molecular Devices has announced the launch of its SpectraMax i3 multi-Mode detection platform.
Available as a stand-alone reader, there is also the option for users to upgrade to additional applications and detection modes such as cellular imaging with the SpectraMax MiniMax Imaging Cytometer, and cartridges for Time-Resolved Fluorescence, Fluorescence Polarisation, and AlphaScreen assays.
The highly sensitive instrument is designed to meet the budget and throughput needs of both small and large laboratories.
Using a combination of a flash lamp for spectral flexibility and light emitting diodes (LEDs) for excitation power, Molecular Devices has developed the patent-pending Spectral Fusion Illumination to deliver wavelength flexibility whilst maximising signal strength, ultimately increasing overall performance.
Data from the SpectraMax i3 System is captured and analysed using Molecular Devices’ SoftMax Pro Software.
The newly updated interface and Spectral Optimisation Wizard is claimed to simplify the workflow and provide powerful data analysis features. The SpectraMax i3 System is also available for use in GMP and GLP labs when used with the SoftMax Pro 6.3 GxP Microplate Data Compliance Software.
Product features
- Features an integrated optical system enabling top and bottom reads for 6 - 384 well microplates and launches with three broad detection modes: luminescence, absorbance, and fluorescence.
- Patented user-exchangeable cartridge design expands the system’s detection capability.
- The MiniMax Imaging Cytometer module adds cellular imaging to a multi-mode detection platform, enabling fluorescence and bright field cellular imaging.
- Combining cellular imaging with microplate-based applications offers new ways for scientists to compress their workflows and increase efficiency.
